1 / 18

Autoimmunity

Autoimmunity. Autoimmunity. Loss of self tolerace leading to immune response to self tissues May be organ-specific, localized or systemic Genetic background plays a role in extent & severity of diseases. Virtually all autoimmune responses are T-dep. Formation of new or altered epitopes

carver
Télécharger la présentation

Autoimmunity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoimmunity

  2. Autoimmunity • Loss of self tolerace leading to immune response to self tissues • May be organ-specific, localized or systemic • Genetic background plays a role in extent & severity of diseases. • Virtually all autoimmune responses are T-dep. • Formation of new or altered epitopes • Sharing epitopes between tissues & agents (molecular mimicry) • Exposure of hidden antigens • Viral infections • Loss of control of lymphocyte responses

  3. Assumption of NO autoimmunity- T cell unresponsiveness because of : • Clonal deletion • T-suppression • Clonal anergy • Inadequate anto-antigen presentation

  4. Criteria for autoimmune disease • Direct proof • Transferring autoantibodies or self-reactive lymphocytes to healthy individuals & reproduce the disease (for ethical reason, use scid mice) • Indirect proof • Identify target antigen & reproduce the disease in the experimental animals • Study genetically predisposed animal models • Circumstantial evidence • Familial tendency • Lymphocyte infiltration or MHC association • Clinical improvement with immune suppressive drugs

  5. Figure 17.1Possible mechanisms of induction of autoimmunity.

  6. Normal thyroid gland Gland in Hashimoto’s thyroiditis

  7. Figure 17.2``Lumpy-bumpy'' staining pattern of fluorescent antibody specific for human Ig: immune aggregate deposits in glomerular basement membrane. [Courtesy of Dr. Angelo Ucci, Tufts University School of Medicine.]

  8. Islet of Langerhans in pacreas from a normal mouse (a) and from a mouse with a disease resembling insulin-dependent diabetes mellitus (b)

  9. “Butterfly” rash over the cheeks of a young girl with systemic lupus erythematosus

  10. Rheumatoid arthirtis

  11. Proposed mechanisms for induction of autoimmunity • Release of sequestered antigens • Molecular mimicry • Inappropriate expression of class II MHC molecules • Polyclonal B cell activation

  12. Treatment of autoimmune diseases • Current therapies • Immunosuppressive drugs • Removal of target tissues • Experimental therapeutic approaches • T cell vaccination • Peptide blockade of MHC molecules • Monoclonal-antibody treatment • Tolerance induction by oral antigens

More Related